Board of Directors

Officers:

PRESIDENT - JOHN FARRAR
John T. Farrar, MD, PhD. is a Professor of Epidemiology (primary), Neurology (secondary), and Anesthesia (secondary) at the Perelman School of Medicine (PSOM) at the University of Pennsylvania.  He received his MD from the University of Rochester, and MSCE and PhD in pharmacoepidemiology from the University of Pennsylvania.  He has been a funded investigator in clinical research for over 25 years with a major focus on studies of the efficacy of pain therapeutics and design of pain clinical trials. As a neurologist and a pharmacoepidemiologist, he has been involved in numerous studies including randomized trials (RCTs), cohort studies, and methodologic studies of pain and associated symptoms, making important contributions to the measurement, analysis, and interpretation of pain related studies.  At the University of Pennsylvania Perelman School of Medicine, he has co-directed the Biostatistical Analysis Center and for 15 years the Master of Science in Clinical Epidemiology (MSCE) program, a two-year masters program focused on training 25-30 fellows per year to launch their careers as independently funded scientists in clinical research.  In his mentoring role he has worked with a diverse group of more than 25 fellows, been primary mentor on several career development awards and teaches courses in health measurement, clinical trials, and grant writing.  He currently is a member of multiple Special Interest Groups in the IASP and was previously the co-Director of the Pain Measurement SIG for the APS as well as a member of the APS board.

DISCLOSURES: Vertex Pharam (consulting fees)

PAST PRESIDENT - MICHAEL GOLD
Michael S. Gold, Ph.D., is a Professor of Neurobiology at the University of Pittsburgh. Dr. Gold received his B.A. from UC Berkeley, Ph.D. from UCLA, and was postdoctoral fellow with Jon Levine at USCF.  For the last twenty years, Gold’s research focused on the neurobiology of pain.  He has made important contributions to injury-induced plasticity in nociceptive afferents, and their contribution to the manifestation of persistent pain. Toward this end, he has employed an array of approaches ranging from the study of isolated cells to the development of novel behavioral assays with which to assess the presence of persistent hypersensitivity, and more recently the study of clinical populations suffering from persistent pain. Dr. Gold has been actively involved in the greater pain community where he was a member of Council for the International Association for the Study of Pain (2012-2018) and a member of the executive committee of the North American Pain School (2015-2019). He was the Chair of the Scientific Program Committee for the American Pain Society (2017) and the International Association for the Study of Pain (2018) and received the F.W.L. Kerr award for basic science research in 2016.

DISCLOSURE: Grunenthal (non-publicly traded entity) 

TREASURER - YENISEL CRUZ-ALMEIDA 

DISCLOSURES: Journal of Pain (Associate Editor)

Award from the American Academy of Hospice and Palliative Medicine, and a Cambia Foundation Sojourns Scholar Leadership Award.

DISCLOSURES: Grant recipient, Cambia Health Foundation (non-publicly traded entity), Center to Advance Palliative Care 

Directors:

Staja "Star" Booker, PhD, RN is an Assistant Professor of Nursing at the University of Florida (UF). Dr. Booker received her BSN from Grambling State University, M.S. from Penn State University, Ph.D. from the University of Iowa, and was a postdoctoral fellow with Dr. Roger Fillingim at the UF. For nearly 10 years, Star’s research has focused on pain disparities, using mixed methods to understand the management of pain in older adults. Currently, her work is phenotyping movement-evoked pain by identifying biopsychosocial-behavioral predictors in older African Americans and White Americans. She has made significant contributions to the assessment of pain in older adults and to understanding the lived experience of older African Americans with persistent pain. An engaged scientist, she has contributed to over 35 peer-reviewed articles, 6 book chapters, and nearly 70 research abstracts and scientific presentations. She has received numerous awards and publication accolades. Dr. Booker is actively involved in several organizations such as the International Association for the Study of Pain, American Society for Pain Management Nursing, the Gerontological Society of America, and the American Nurses Association.

DISCLOSURES: None 

Andrea Nackley, Ph.D. is an Associate Professor in the Department of Anesthesiology’s Center for Translational Pain Medicine (CTPM) at Duke University School of Medicine. She is Director of the Translational Pain Research Laboratory, where her program marries pain neurobiology, behavioral pharmacology, and molecular genetics in mouse and man to to better understand mechanisms of and identify treatments for chronic ‘primary’ overlapping pain conditions. Her lab was the first to demonstrate a critical role for peripheral adrenergic receptor beta-3 in the development of chronic pain and neuroinflammation, which remains a primary research focus. In recognition of her research and scholarly activity in the pain field, Dr. Nackley received the John C. Liebeskind Early Career Scholar Award in 2010 from the American Pain Society. She has remained actively engaged in the pain community, serving as Co-Chair of the American Pain Society’s Genetics and Pain Special Interest Group, Member of the Nominating Committee, and Chair of the Early Career Forum. She is an Associate Editor for Frontiers in Pain Research and Member of the USASP Board of Directors. In her role on the Board of Directors, she will work to emphasize translational aspects of basic science research and education as well as to promote diversity, equity, and inclusion in line with the vision of the USASP.

DISCLOSURES: None

Rachel Zoffness, Ph.D. is a pain psychologist, medical educator, and leader in the field of pain education. She is an Assistant Clinical Professor at UCSF, a Visiting Professor at Stanford, and a Mayday Fellow. Dr. Zoffness is the author of The Pain Management Workbook, a treatment protocol for adults and healthcare providers, and The Chronic Pain and Illness Workbook for Teens, the first pain workbook for kids. She has served on the boards of the U.S. Association for the Study of Pain, The American Association of Pain Psychology, and the Society of Pediatric Pain Medicine, and consults on the development of integrative pain programs around the world. A passionate pain educator, her pain science podcast episodes have over 5 million downloads. Dr. Zoffness was trained at Brown, Columbia, UCSD, NYU, and Mt. Sinai Hospital.

DISCLOSURES: None

Ericka Merriwether, P.T., D.P.T., Ph.D. is an Assistant Professor in the Departments of Physical Therapy and Medicine and is the Director of the Inclusive and Translational Research in Pain Laboratory (I-TRIP) at New York University. The goal of her research is to identify targets for culturally responsive, multimodal interventions for chronic widespread musculoskeletal pain in adults with a diversity of body sizes and phenotypes. To achieve this goal, Dr. Merriwether's current projects focus on identifying key biopsychosocial and socioecological drivers of pain variability,  and how these candidate drivers of pain variability respond to weight change. This highly interdisciplinary work employs a variety of clinical and translational research methodologies. Also, Dr. Merriwether is a proud native of Chicago’s Austin Community on the city’s West side, and is the mother of two amazing children.

Dr. Merriwether earned her Bachelor of Science in Kinesiology from the University of Illinois at Urbana-Champaign. She went on to earn her DPT from the Mayo Clinic School of Health Sciences, and her PhD in Movement Science from Washington University in St. Louis. Dr. Merriwether completed postdoctoral fellowship in pain neuroscience in the Department of Physical Therapy and Rehabilitation Science at the University of Iowa prior to her current faculty appointment. Her research has been supported by the National Institutes of Health, the Foundation for Physical Therapy, and most recently, the NYU CoHRR. Dr. Merriwether has several publications in pain and rehabilitation journals, and currently serves as an Editorial Board member for the Journal of Pain, Frontiers in Pain Research, and the Neurobiology of Pain. She also serves on the Board of Directors for the United States Association for the Study of Pain (USASP), has served as an Early Career Reviewer for the Neurobiology of Pain and Itch Study Section at NIH, and is an executive member of the Anti-racism CoaliTION in Pain Research (ACTION-PR). 

DISCLOSURES: None 

Daniela Maria Menichella, MD, PhD is a physician-scientist who graduated from the Neurology Residency Program at Northwestern University in Chicago and from the NIH R25 program. She secured a K08 career development award and received an early-stage investigator NIH R01 grant. Dr Menichella is now an Assistant Professor of Neurology and Pharmacology at Northwestern University. She is a neurologist taking care of patients with painful peripheral neuropathy and acts as the director of the Peripheral Neuropathy Clinic and of the Charcot-Marie-Tooth Association Center of Excellence. Dr Menichella is actively engaged in basic science and translational research, including NIH NeuroNext Clinical trails. She is the Principal Investigator of an NIH funded laboratory that investigates the molecular and physiological mechanisms underlying neuropathic pain in hereditary and acquired peripheral neuropathies with a particular focus on Painful Diabetic Neuropathy. Towards designing more effective therapeutics, Dr Menichella’s laboratory takes advantage of an integrated approach combining pain behavioral tests, electrophysiology studies including current-clamp recordings, in vitro and in vivo calcium imaging studies, confocal studies, chemogenetics and single-cell RNA sequencing with conditional and transgenic mouse models.  In addition to her work at Northwestern University, she serves in the Board of Directors of the Peripheral Nerve Society (PNS), and as a K Career Development physician-scientist mentor at the NINDS/American Neurological Association (ANA).  

DISCLOSURES: Associate Editor of Diabetes 

Vitaly Napadow, Ph.D. is an Associate Professor at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital and Harvard Medical School in Boston, MA, where he is also the Director of the Center for Integrative Pain Neuroimaging (CiPNI). Dr. Napadow received his PhD in biomedical engineering from MIT and Harvard Medical School. Somatosensory, cognitive, and affective factors all influence the malleable experience of chronic pain, and Dr. Napadow’s Lab has applied human functional and structural neuroimaging to localize and suggest mechanisms by which different brain circuitries modulate pain perception. Dr. Napadow’s neuroimaging research also aims to better understand how non-pharmacological therapies, from acupuncture and transcutaneous neuromodulation to cognitive behavioral therapy and mindfulness meditation training, ameliorate these states. Dr. Napadow has more than 160 publications in leading peer-reviewed scientific journals, is past-President of the Society for Acupuncture Research, and serves on numerous conference, journal, and NIH review panels. He was recently named to the Academy Distinguished Investigator Council by the Academy for Radiology & Biomedical Imaging Research and received the Excellence in Integrative Medicine Research Award by the European Society for Integrative Medicine.

DISCLOSURES: Cala Health, Inc. (consulting fees), Click Therapeutics, Inc. (consulting fees)

 DISCLOSURES: Elsevier book royalties, Lumina Health royalties 

Daniela Salvemini, Ph.D is William Beaumont Professor and Chair of the Department of Pharmacology and Physiology at Saint Louis University (SLU) School of Medicine, Professor of Psychiatry and Behavioral Neuroscience and Director of SLU’s Institute for Translational Neuroscience. Dr. Salvemini received her BSc in Pharmacology from Kings College in London and her PhD in Pharmacology from the University of London under the mentorship of the late Nobel Prize winner Professor Sir John Vane. She pursued postdoctoral studies at the William Harvey Research Institute in London and in the Department of Discovery Pharmacology at Monsanto in Saint Louis. Before joining SLU in 2005, Dr Salvemini spent 15 years in the private sector where she led drug discovery efforts on novel anti-inflammatory agents and analgesics. Dr Salvemini’s research interests are to understand the cellular and molecular mechanisms underpinning neuropathic pain and developing therapeutics to target these mechanisms. Her highly translational approaches combine behavioral pharmacology, biochemistry, molecular biology, genetics, toxicology and drug discovery. Her work led to several seminal discoveries that resulted in the development of novel therapies that entered clinical trials. She has published over 270 peer-reviewed articles and holds many U.S. patents. Dr. Salvemini is founder of BioIntervene Inc, which is developing first-in-class selective A3AR agonists for the treatment of chronic pain and neuroinflammatory diseases and founding Director of the Henry and Amelia Nasrallah Center for Neuroscience at SLU. She is a board member of the United States Association for the Study of Pain. Dr. Salvemini has been honored with several awards for her basic science and translational research in pain and inflammation, including the Novartis Award in Pharmacology, the Outstanding Scientist Award from the Saint Louis Academy of Science and the Pharmacia-ASPET Award in Experimental Therapeutics. Dr. Salvemini is a fellow of the Saint Louis Academy of Science, a fellow of the National Academy of Inventors and a fellow of the American Society of Pharmacology and Experimental Therapeutics. Her research has been funded consistently by the NIH, foundations and the private sector.